Herein we highlight the biology and biochemistry of the PAM axis, describe its major dysregulations in cancer, show its main crosstalks with other signaling pathways, and discuss PI3K-, AKT-, mTOR-, and PDK1-targeted inhibitors, emphasizing on their mechanisms of therapeutic resistance. Here, AKT1 is linked to cancer.